News and Announcements
DroneShield wins an Australian Department of Defence open tender for portable unmanned aerial system detection devices
- Published November 26, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
On 1 October 2019 DroneShield Ltd (ASX:DRO or DRO.AU) (“DroneShield” or the “Company”) announced that it had won an Australian Department of Defence open tender for portable unmanned aerial system detection devices, in the aggregate amount of approximately A$700,000 and that it expected to deliver the products during the calendar 2019.
These products were shipped to the Australian Department of Defence today, with the payment of approximately A$565,000, for the initial purchase price, expected to be received from the Australian Government this quarter.
DroneShield’s CEO Oleg Vornik commented, “This order is particularly important for us since this is the first sizeable order for our portable drone detection device RfPatrol™ and the first order from the Australian Defence Force.”
About DroneShield
Based in Sydney (Australia), Virginia and Washington, DC (USA) and London (UK), DroneShield is a worldwide leader in drone security technology. The Company has developed the pre-eminent drone security solution that protects people, organisations and critical infrastructure from intrusion from drones. Its leadership brings world-class expertise in engineering and physics, combined with deep experience in defence, intelligence, and aerospace.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
